Banerjee Soojay, Bartesaghi Alberto, Merk Alan, Rao Prashant, Bulfer Stacie L, Yan Yongzhao, Green Neal, Mroczkowski Barbara, Neitz R Jeffrey, Wipf Peter, Falconieri Veronica, Deshaies Raymond J, Milne Jacqueline L S, Huryn Donna, Arkin Michelle, Subramaniam Sriram
Laboratory of Cell Biology, National Cancer Institute, Bethesda, MD 20892, USA.
Small Molecule Discovery Center, Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, CA 94143, USA.
Science. 2016 Feb 19;351(6275):871-5. doi: 10.1126/science.aad7974. Epub 2016 Jan 28.
p97 is a hexameric AAA+ adenosine triphosphatase (ATPase) that is an attractive target for cancer drug development. We report cryo-electron microscopy (cryo-EM) structures for adenosine diphosphate (ADP)-bound, full-length, hexameric wild-type p97 in the presence and absence of an allosteric inhibitor at resolutions of 2.3 and 2.4 angstroms, respectively. We also report cryo-EM structures (at resolutions of ~3.3, 3.2, and 3.3 angstroms, respectively) for three distinct, coexisting functional states of p97 with occupancies of zero, one, or two molecules of adenosine 5'-O-(3-thiotriphosphate) (ATPγS) per protomer. A large corkscrew-like change in molecular architecture, coupled with upward displacement of the N-terminal domain, is observed only when ATPγS is bound to both the D1 and D2 domains of the protomer. These cryo-EM structures establish the sequence of nucleotide-driven structural changes in p97 at atomic resolution. They also enable elucidation of the binding mode of an allosteric small-molecule inhibitor to p97 and illustrate how inhibitor binding at the interface between the D1 and D2 domains prevents propagation of the conformational changes necessary for p97 function.
p97是一种六聚体AAA+三磷酸腺苷酶(ATP酶),是癌症药物开发的一个有吸引力的靶点。我们报告了在存在和不存在变构抑制剂的情况下,二磷酸腺苷(ADP)结合的全长六聚体野生型p97的低温电子显微镜(cryo-EM)结构,分辨率分别为2.3和2.4埃。我们还报告了p97的三种不同共存功能状态的低温电子显微镜结构(分辨率分别约为3.3、3.2和3.3埃),每个原体中腺苷5'-O-(3-硫代三磷酸)(ATPγS)的占据量为零、一或两个分子。仅当ATPγS与原体的D1和D2结构域都结合时,才观察到分子结构的巨大螺旋状变化,以及N末端结构域的向上位移。这些低温电子显微镜结构在原子分辨率上确定了p97中核苷酸驱动的结构变化序列。它们还能够阐明变构小分子抑制剂与p97的结合模式,并说明抑制剂在D1和D2结构域之间的界面处结合如何阻止p97功能所需的构象变化的传播。